The Tyrosine Phosphatase SHP2 Regulates Focal Adhesion Kinase to Promote EGF-Induced Lamellipodia Persistence and Cell Migration

被引:55
|
作者
Hartman, Zachary R. [1 ]
Schaller, Michael D. [1 ]
Agazie, Yehenew M. [1 ,2 ]
机构
[1] W Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA
[2] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA
关键词
EPIDERMAL-GROWTH-FACTOR; HELICOBACTER-PYLORI CAGA; NEGATIVE BREAST-CANCER; ACUTE MYELOID-LEUKEMIA; MOLECULAR-MECHANISM; PTPN11; MUTATIONS; NOONAN-SYNDROME; FACTOR RECEPTOR; PROTEIN; ACTIVATION;
D O I
10.1158/1541-7786.MCR-12-0578
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Src homology phosphotyrosyl phosphatase 2 (SHP2) is a positive effector of receptor tyrosine kinases (RTK) signaling. Furthermore, SHP2 is known to promote cell migration and invasiveness, key steps in cancer metastasis. To date, however, the mechanism by which SHP2 regulates cell movement is not fully understood. In the current report, a new role for SHP2 in regulating cell migration has been suggested. We show that SHP2 mediates lamellipodia persistence and cell polarity to promote directional cell migration in the MDA-MB231 and the MDA-MB468 basal-like and triple-negative breast cancer cell lines. We further show that SHP2 modulates the activity of focal adhesion kinase (FAK) by dephosphorylating pTyr397, the autophosphorylation site that primes FAK function. Because hyperactivation of FAK is known to counter the maturation of nascent focal complexes to focal adhesions, we propose that one of the mechanisms by which SHP2 promotes lamellipodia persistence is by downregulating FAK activity through dephosphorylation of pTyr397. The finding that inhibition of FAK activity partially restores EGF-induced lamellipodia persistence and cell migration in SHP2-silenced cells supports our proposition that SHP2 promotes growth factor-induced cell movement by acting, at least in part, on FAK. However, the effect of SHP2 inhibition in nonstimulated cells seems FAK independent as there was no significant difference between the control and the SHP2-silenced cells in pY397-FAK levels. Also, FAK inhibition did not rescue Golgi orientation defects in SHP2-silenced cells, suggesting that SHP2 acts through other mechanisms to promote cell polarity. (C)2013 AACR.
引用
收藏
页码:651 / 664
页数:14
相关论文
共 50 条
  • [41] Protein tyrosine phosphatase SHP2 is involved in Semaphorin 4D-induced axon repulsion
    Fuchikawa, Taro
    Nakamura, Fumio
    Fukuda, Nana
    Takei, Kohtaro
    Goshima, Yoshio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (01) : 6 - 10
  • [42] Tyrosine phosphorylation of vimentin intermediate filaments regulated by Src and SHP2 is important for cell migration
    Yang, C.
    Chang, P.
    Chen, C.
    Hsu, W.
    Lai, C.
    Chiu, W.
    Chen, H.
    FEBS OPEN BIO, 2018, 8 : 337 - 337
  • [43] The Role of Protein Tyrosine Phosphatase, Shp2, in FLT3-ITD-Induced Leukemogenesis.
    Nabinger, Sarah C.
    Fukuda, Seiji
    Kapur, Reuben
    Chan, Rebecca
    BLOOD, 2008, 112 (11) : 636 - 636
  • [44] SHP2 protein-tyrosine phosphatase is a key regulator of mast cell signaling and development in mice
    Sharma, Namit
    Everingham, Stephanie
    Feng, Gen-Sheng
    Roers, Axel
    Craig, Andrew
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [45] SHP-2 tyrosine phosphatase regulates thrombin-induced expression of adhesion molecules in human aortic endothelial cells
    Low, B
    Hao, Q
    Tang, H
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A40 - A40
  • [46] Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility
    Brown, C
    Lin, Y
    Hassid, A
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (04): : H1598 - H1605
  • [47] KIT Induced Myeloproliferative Disease Is Dependent on PI3Kinase and SHP2 Phosphatase: Identification of SHP2 As a Druggable Target for Treating MPD and AML
    Ma, Peilin
    Mali, Raghuveer
    Zeng, Li-Fan
    Martin, Holly
    Ramdas, Baskar
    He, Yantao
    Sims, Emily
    Ghosh, Joydeep
    Nabinger, Sarah C.
    Li, Shuo
    Munugalavadla, Veerendra
    Chatterjee, Anindya
    Sandusky, George
    Craig, Andrew
    Bunting, Kevin D.
    Feng, Gen-Sheng
    Chan, Rebecca J.
    Zhang, Zhong-Yin
    Kapur, Reuben
    BLOOD, 2011, 118 (21) : 396 - 396
  • [48] The tyrosine phosphatase SHP2 regulates YAPY357 phosphorylation, subcellular localization, and transcriptional coactivity in cholangiocarcinoma.
    Buckarma, EeeLN
    Werneburg, Nathan
    Kabashima, Ayano
    Gores, Gregory
    Smoot, Rory
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 31 - 31
  • [49] The protein-tyrosine-phosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase c α, β1, β2 and η
    Strack, V
    Kellerer, M
    Lammers, R
    Haering, HU
    DIABETES, 2001, 50 : A401 - A401
  • [50] Protein kinase a suppresses antiproliferative effect of interferon-α in hepatocellular carcinoma by activation of protein tyrosine phosphatase SHP2
    Sheng, Yuwen
    Lin, Yuan
    Qiang, Zhe
    Shen, Xiaofei
    He, Yujiao
    Li, Lingyu
    Li, Sheng
    Zhang, Guolin
    Wang, Fei
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (02)